| 36.78 Data as of May 23 | +0.57 / +1.57%Today’s Change | 17.06 Today|||52-Week Range 42.41 | +65.38% Year-to-Date |
| Elan Provides Strategic Update - Analyst Blog May 21 / Zacks.com | Elan in Royalty Deal with THRX - Analyst Blog May 14 / Zacks.com |
| Elan steps up fight against Royalty Pharma bid May 20 / FT.com | Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog May 13 / Zacks.com |